The Accelerator is a first-in-kind, transatlantic initiative to identify, fund and advance breakthrough academic discoveries to deliver new treatments for the 400 million people worldwide who suffer from rare diseases. David Cameron said: 'I know from my own experience of having a son born with an incredibly rare and incurable disease, how little we really know about rare diseases. The partners are also collaborating to create a dedicated Rare Disease Impact Fund to enable investments in mission-aligned projects and accelerate the development of rare disease therapeutics. Already we have seen many exciting opportunities and look forward to engaging with scientists at the forefront of rare disease research.' Leveraging the unique Harrington model in the Oxford-Harrington Rare Disease Centre will catalyze the development of new medicines for hundreds of thousands of patients across the globe.'